| Dr Theodore G Pettle, MD | |
|
1700 Se Hillmoor Dr, Port St Lucie, FL 34952-7539 | |
| (772) 335-9600 | |
| Not Available |
| Full Name | Dr Theodore G Pettle |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 14 Years |
| Location | 1700 Se Hillmoor Dr, Port St Lucie, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003102211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | R6457 (Texas) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | ME139195 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Texas Health System | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcallen Hospitalist Group Pllc | 9830113836 | 99 |
News Archive
A large study focused on documenting the strength and fitness of childhood brain tumor survivors has found that many face health challenges as they age. The study led by St. Jude Children's Research Hospital investigators showed that although most participants were young adults in their 20s, many functioned like people in their 60s, making them less likely to live independently or attend college.
Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.
Progenics Pharmaceuticals, Inc. today reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate designed to selectively deliver chemotherapy to cells that express prostate-specific membrane antigen.
› Verified 5 days ago
| Entity Name | Mcallen Hospitalist Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356361976 PECOS PAC ID: 9830113836 Enrollment ID: O20060117001076 |
News Archive
A large study focused on documenting the strength and fitness of childhood brain tumor survivors has found that many face health challenges as they age. The study led by St. Jude Children's Research Hospital investigators showed that although most participants were young adults in their 20s, many functioned like people in their 60s, making them less likely to live independently or attend college.
Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.
Progenics Pharmaceuticals, Inc. today reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate designed to selectively deliver chemotherapy to cells that express prostate-specific membrane antigen.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theodore G Pettle, MD 1700 Se Hillmoor Dr, Port St Lucie, FL 34952-7539 Ph: (772) 335-9600 | Dr Theodore G Pettle, MD 1700 Se Hillmoor Dr, Port St Lucie, FL 34952-7539 Ph: (772) 335-9600 |
News Archive
A large study focused on documenting the strength and fitness of childhood brain tumor survivors has found that many face health challenges as they age. The study led by St. Jude Children's Research Hospital investigators showed that although most participants were young adults in their 20s, many functioned like people in their 60s, making them less likely to live independently or attend college.
Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.
Progenics Pharmaceuticals, Inc. today reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate designed to selectively deliver chemotherapy to cells that express prostate-specific membrane antigen.
› Verified 5 days ago
Alan Steven Collin, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1871 Se Tiffany Ave, Suite 100, Port St Lucie, FL 34952 Phone: 772-335-5666 Fax: 772-335-4826 | |
Dr. Gerald John Rutecki, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 473 Nw Blue Lake Dr, Port St Lucie, FL 34986 Phone: 772-336-8039 | |
Dr. Dana D Dameron Jr., D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 475 Nw Prima Vista Blvd, Port St Lucie, FL 34983 Phone: 772-800-3037 Fax: 772-807-1409 | |
Ahmet Bahadir Ergin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1700 Se Hillmoor Dr, Port St Lucie, FL 34952 Phone: 772-335-9600 Fax: 772-335-7972 | |
Dr. Philip Lortz, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1855 Se Port St Lucie Blvd, Port St Lucie, FL 34952 Phone: 772-288-6300 Fax: 772-288-6374 | |
Edwin Benedict Flanagan, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1651 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-1800 Fax: 772-398-1815 |